
Sign up to save your podcasts
Or


Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.
By Venrock, a venture capital firm4.8
6262 ratings
Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.

1,296 Listeners

2,672 Listeners

2,461 Listeners

1,105 Listeners

341 Listeners

337 Listeners

394 Listeners

5,610 Listeners

10,254 Listeners

34 Listeners

551 Listeners

21 Listeners

300 Listeners

475 Listeners

1,480 Listeners